Poo, Jorge Luis <br/><br/>
Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Dec 2004 
 - S79-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2004.03634.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Mexico<br/>Middle Aged<br/>Pilot Projects<br/>Polyethylene Glycols--therapeutic use<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>Thymalfasin<br/>Thymosin--analogs & derivatives<br/>Time Factors<br/>Treatment Failure<br/>Treatment Outcome<br/>Viral Load<br/>Virus Replication--drug effects